Cancer Research Funding

Share

Cancer research saves lives and makes more time for survivors.

By investing in the research of today, Congress can help prevent, detect, and treat many of the cancers of tomorrow, creating countless moments for patients and their loved ones in the process.

Every major breakthrough in the fight against cancer has one thing in common: the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.

Increased funding for cancer research lengthens and saves lives and must be a top budget priority for Congress.

Take Action

capital celebration volunteers cropped

Urge Congress to increase funding for cancer research

Lives are on the line. Sign the petition today, and urge Congress to increase cancer research funding.

Latest Updates

August 13, 2024
National

President Biden and the First Lady will announce the next step in the Cancer Moonshot Initiative today in New Orleans.

August 2, 2024
National

This week, the U.S. Senate Committee on Appropriations considered and approved its draft FY25 appropriations bill that includes significant increases for the NIH, increases for NCI and an increase for CDC's Division of Cancer Prevention and Control.

June 27, 2024
National

Today, the House Appropriations Subcommittee on Labor Health and Human Services considered and approved its draft FY25 appropriations bill that includes increases for federal cancer research funding at the National Cancer Institute (NCI).

May 15, 2024
National

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.

Cancer Research Funding Resources

The Clinical Trial Modernization Act (H.R. 8412) would increase access to clinical trials by allowing clinical trial sponsors to provide financial support to patients for costs associated with their trial participation, including medical cost-sharing like copays, and non-medical expenses such as travel, parking, food and lodging.

To ensure that the research being supported today yields the cancer treatments of tomorrow, Congress must sustain and expand the support it is currently providing.

By focusing explicitly on bold, transformative, and applied research projects, ARPA-H holds the potential to quickly bridge the gap between the research lab and the patient.